STOCK TITAN

Conference call interim report

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Vitrolife AB (VTRLY) has announced a conference call to present its Q1 2025 interim report scheduled for Thursday, April 24, 2025, at 10:00 AM CET. The presentation will be conducted in English.

Key participants from Vitrolife include CEO Bronwyn Brophy O'Connor and acting CFO Helena Wennerström. The interim report press release will be published at 8:00 AM CET on the same day, with presentation materials available on the company website before the call.

Interested parties must register to receive telephone numbers and access PINs for the conference. A recorded version will be accessible for seven days following the call at +44 (0) 20 3451 9993 using access code 8141544#.

Vitrolife AB (VTRLY) ha annunciato una conferenza telefonica per presentare il suo rapporto intermedio Q1 2025, programmata per giovedì 24 aprile 2025, alle 10:00 AM CET. La presentazione sarà condotta in inglese.

I partecipanti chiave di Vitrolife includono l'Amministratore Delegato Bronwyn Brophy O'Connor e l'attuale CFO Helena Wennerström. Il comunicato stampa del rapporto intermedio sarà pubblicato alle 8:00 AM CET lo stesso giorno, con i materiali della presentazione disponibili sul sito web dell'azienda prima della chiamata.

Le parti interessate devono registrarsi per ricevere i numeri di telefono e i codici di accesso per la conferenza. Una registrazione della chiamata sarà accessibile per sette giorni dopo la conferenza al numero +44 (0) 20 3451 9993 utilizzando il codice di accesso 8141544#.

Vitrolife AB (VTRLY) ha anunciado una llamada de conferencia para presentar su informe intermedio Q1 2025, programada para el jueves 24 de abril de 2025, a las 10:00 AM CET. La presentación se llevará a cabo en inglés.

Los participantes clave de Vitrolife incluyen a la CEO Bronwyn Brophy O'Connor y la CFO interina Helena Wennerström. El comunicado de prensa del informe intermedio se publicará a las 8:00 AM CET el mismo día, con los materiales de presentación disponibles en el sitio web de la empresa antes de la llamada.

Las partes interesadas deben registrarse para recibir los números de teléfono y los códigos de acceso para la conferencia. Una versión grabada estará accesible durante siete días después de la llamada al +44 (0) 20 3451 9993 utilizando el código de acceso 8141544#.

Vitrolife AB (VTRLY)는 2025년 1분기 중간 보고서를 발표하기 위한 전화 회의를 2025년 4월 24일 목요일, CET 기준 오전 10시에 개최한다고 발표했습니다. 발표는 영어로 진행됩니다.

Vitrolife의 주요 참여자는 CEO 브론윈 브로피 오코너임시 CFO 헬레나 베너스트롬입니다. 중간 보고서 보도 자료는 같은 날 오전 8시 CET에 발표되며, 회의 전에 회사 웹사이트에서 발표 자료를 확인할 수 있습니다.

관심 있는 당사자는 전화 번호와 회의 접근 PIN을 받기 위해 등록해야 합니다. 회의 후 7일 동안 +44 (0) 20 3451 9993에서 접근 코드 8141544#를 사용하여 녹음된 버전을 이용할 수 있습니다.

Vitrolife AB (VTRLY) a annoncé une conférence téléphonique pour présenter son rapport intermédiaire Q1 2025, prévue pour jeudi 24 avril 2025, à 10h00 CET. La présentation sera réalisée en anglais.

Les participants clés de Vitrolife incluent la PDG Bronwyn Brophy O'Connor et la CFO par intérim Helena Wennerström. Le communiqué de presse du rapport intermédiaire sera publié à 8h00 CET le même jour, avec les documents de présentation disponibles sur le site Web de l'entreprise avant l'appel.

Les parties intéressées doivent s'inscrire pour recevoir les numéros de téléphone et les codes d'accès pour la conférence. Une version enregistrée sera accessible pendant sept jours après la conférence au +44 (0) 20 3451 9993 en utilisant le code d'accès 8141544#.

Vitrolife AB (VTRLY) hat eine Telefonkonferenz angekündigt, um ihren Zwischenbericht Q1 2025 zu präsentieren, die für Donnerstag, den 24. April 2025, um 10:00 Uhr CET geplant ist. Die Präsentation wird auf Englisch durchgeführt.

Wichtige Teilnehmer von Vitrolife sind CEO Bronwyn Brophy O'Connor und die amtierende CFO Helena Wennerström. Die Pressemitteilung zum Zwischenbericht wird am selben Tag um 8:00 Uhr CET veröffentlicht, und die Präsentationsmaterialien werden vor der Konferenz auf der Unternehmenswebsite verfügbar sein.

Interessierte Parteien müssen sich registrieren, um Telefonnummern und Zugangscodes für die Konferenz zu erhalten. Eine aufgezeichnete Version wird sieben Tage nach der Konferenz unter +44 (0) 20 3451 9993 mit dem Zugangscode 8141544# verfügbar sein.

Positive
  • None.
Negative
  • None.

GOTHENBURG, Sweden, April 10, 2025 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q1 2025. The presentation will be held in English.

Time: Thursday 24 April, 2025 at 10.00 a.m. CET. 

To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy

Register for the call here

Vitrolife Group participants:
Bronwyn Brophy O´Connor, CEO
Helena Wennerström, acting CFO

The press release for the interim report will be released at 8.00 CET on the same day. 

Before the conference call, presentation material will be available at the company web page.

A recorded version of the telephone conference will be available for seven days on number +44 (0) 20 3451 9993 (International), access code 8141544#.

Gothenburg, 10 April 2025
VITROLIFE AB (publ) 

Contact:
Amelie Wilson, Investor Relations, awilson@vitrolife.com

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/vitrolife-ab--publ-/r/conference-call-interim-report,c4133413

The following files are available for download:

https://mb.cision.com/Main/1031/4133413/3379023.pdf

Conference call interim report

 

Cision View original content:https://www.prnewswire.com/news-releases/conference-call-interim-report-302425490.html

SOURCE Vitrolife AB (publ)

FAQ

When is Vitrolife's (VTRLY) Q1 2025 earnings call scheduled?

Vitrolife's Q1 2025 earnings call is scheduled for Thursday, April 24, 2025, at 10:00 AM CET.

How can investors access VTRLY's Q1 2025 earnings call?

Investors must register through the provided link to receive telephone numbers and personal PIN access to the conference call.

When will Vitrolife (VTRLY) release its Q1 2025 interim report?

The Q1 2025 interim report press release will be published at 8:00 AM CET on April 24, 2025.

How long will the recording of VTRLY's Q1 2025 earnings call be available?

The recorded version will be available for seven days after the call at +44 (0) 20 3451 9993 with access code 8141544#.

Who are the key executives participating in Vitrolife's Q1 2025 earnings call?

CEO Bronwyn Brophy O'Connor and acting CFO Helena Wennerström will participate in the call.
Vitrolife

OTC:VTRLY

VTRLY Rankings

VTRLY Latest News

VTRLY Stock Data

2.44B
73.63M
Medical Devices
Healthcare
Link
Sweden
Gothenburg